• Publications
  • Influence
Long-term outcomes of Shiga toxin hemolytic uremic syndrome
TLDR
After the acute episode all patients must be followed for at least 5 years, and severely affected patients should be followed indefinitely if there is proteinuria, hypertension or a reduced glomerular filtration rate (GFR). Expand
Insights from the Chronic Kidney Disease in Children (CKiD) study.
TLDR
This interim report is to review the initial cross-sectional data and conclusions derived from the clinical studies conducted within CKiD in the context of findings from other pediatric CKD and end-stage renal disease (ESRD) registry and cohort studies. Expand
Update on Streptococcus pneumoniae associated hemolytic uremic syndrome
TLDR
The pathophysiology, clinical course, treatment and prognosis for SpHUS, which is defined by the occurrence of acute hemolytic anemia, thrombocytopenia and acute kidney injury in a patient with a S. pneumoniae infection is reviewed. Expand
Hypothesis: Dent disease is an underrecognized cause of focal glomerulosclerosis.
TLDR
It is hypothesized that a diagnosis of Dent disease may be unrecognized in patients with unexplained proteinuria and idiopathic focal glomerulosclerosis. Expand
Evaluation and medical management of kidney stones in children.
TLDR
The incidence of kidney stone disease in children is increasing, yet few randomized clinical trials or high quality observational studies have assessed whether dietary or pharmacological interventions decrease the recurrence of kidney stones in children. Expand
Streptococcus pneumoniae-associated hemolytic uremic syndrome
TLDR
In this review, the pathophysiology, clinical features, diagnostic difficulties and management of this potentially under-diagnosed condition are summarized. Expand
Urolithiasis in Children
TLDR
A comprehensive metabolic evaluation is essential for all children with renal calculi, given the high rate of recurrence and the importance of excluding inherited progressive conditions. Expand
Streptococcus pneumoniae–Associated Hemolytic Uremic Syndrome: Classification and the Emergence of Serotype 19A
TLDR
This report provides a rationale for including patients with concurrent disseminated intravascular coagulopathy and/or those whose culture results were negative, and highlights the emergence of serotype 19A subsequent to the introduction of 7-valent pneumococcal protein conjugate vaccine (Prevnar). Expand
The thrombotic microangiopathies
TLDR
This review describes the forms of HUS/TTP that are not related to Shiga toxin, pneumococcal infection, genetic causes, or ADAMTS13 deficiency. Expand
Streptococcus pneumoniae-associated Hemolytic Uremic Syndrome Among Children in North America
TLDR
In this series, North American children with SP-HUS had severe clinical manifestations and significant morbidity, nearly all cases were caused by serotypes that are not in PCV7 but are included inPCV13. Expand
...
1
2
3
4
5
...